Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
S A Gayther, W Warren, S Mazoyer...
https://pubmed.ncbi.nlm.nih.gov/7493024/Actively Recruiting
Led by Institut Paoli-Calmettes · Updated on 2026-10-14
5000
Participants Needed
1
Research Sites
N/A
Total Duration
This research focuses on individuals who carry a BRCA gene mutation, which increases the genetic risk for breast and ovarian cancers. The study aims to observe the incidence of these cancers over a long period, helping to understand the impact of carrying these mutations. Participants include both women and men, with or without existing cancer diagnoses at the start of the study. Participants in this observational study will undergo standardized data collection through questionnaires and will be followed prospectively for 10 years. No experimental treatments are administered instead, the study collects information to monitor health outcomes related to the BRCA gene mutation. During the study, participants will provide data through questionnaires and regular follow-up assessments over the 10-year period. Researchers will measure the occurrence of breast and ovarian cancers during this time. The study includes safety monitoring and long-term observation to better understand cancer risks associated with BRCA mutations.
CONDITIONS
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
D
Dominique GENRE, MD
M
Margot BERLINE, MSc, MBA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Institut Paoli-Calmettes
Lead Sponsor
UNICANCER
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - 10 years
Participants provide standardized questionnaire data and are followed over 10 years to observe health outcomes related to BRCA mutations.
Regular follow-up assessments and data collection visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
S A Gayther, W Warren, S Mazoyer...
https://pubmed.ncbi.nlm.nih.gov/7493024/D Ford, D F Easton, D T Bishop...
https://pubmed.ncbi.nlm.nih.gov/7907678/Nadine Andrieu, David E Goldgar, Douglas F Easton...
https://pubmed.ncbi.nlm.nih.gov/16622123/C Bonaïti-Pellié, N Andrieu, P Arveux...
https://pubmed.ncbi.nlm.nih.gov/19751997/Hongyan Li, Mary Beth Terry, Antonis C Antoniou...
https://pubmed.ncbi.nlm.nih.gov/31792088/Daniel R Barnes, Matti A Rookus, Lesley McGuffog...
https://pubmed.ncbi.nlm.nih.gov/32665703/Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes...
https://pubmed.ncbi.nlm.nih.gov/28632866/Anouk Pijpe, Nadine Andrieu, Douglas F Easton...
https://pubmed.ncbi.nlm.nih.gov/22956590/Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme...
https://pubmed.ncbi.nlm.nih.gov/22762150/C Lerman, S Narod, K Schulman...
https://pubmed.ncbi.nlm.nih.gov/8648868/Institut Paoli-Calmettes
Lead Sponsor
UNICANCER
Collaborating Sponsor